Pepa Lopez Barragan is a trusted expert in regulatory compliance and CMC (Chemistry, Manufacturing, and Controls), bringing a wealth of expertise gained from years of dedicated service at the FDA. Now, as a seasoned regulatory consultant, she leverages her insider knowledge and industry insights to guide pharmaceutical companies through the intricate pathways of product development…
PhD Pharmacology. 30 years in drug development. Market authorization of 7 drugs in EU/US.
Katja Görnemann is a certified EFFAS financial analyst specialized in Equity and Fixed Income Investor Relations (IR), Corporate Development, Corporate Finance and Corporate Communication. His professional development has focused on the preparation and execution of IPOs (Gestevisión Telecinco, Talgo), corporate bond issuances, as well as the design and implementation of IR strategic plans in multinational…
MBA and MS Chemical Eng (MIT). 15 years Executive Director at Novartis. +1B€ in sales in EU/US.
PhD Molecular Biology. +20 years in Licensing, Business Analytics and Strategic Consulting at Roche, PharmaMar and ActeaVentures.
Former Genentech, Roche, NCI, NIH, DHHS, CEO of American Association for Precision Medicine.
Degree in Biotechnology from the University Pablo de Olavide. CFGS in Web Applications Development.
Degree in Communication and Marketing and expert in communication and marketing strategy, with more than twenty years of professional experience launching companies such as: MSI, ASUS, PNY, KIRRIO.
Degree in Biology from the University of Seville. CFGS in Web Applications Development.
Law degree and executive MBA from Instituto de Empresa. Director of Startup Europe Accelerator and STARTUP EUROPE AWARDS of the European Commission. CEO of the Finnova Foundation. Founder ITC SPRL.